Piramal Pharma Consumer Products Division’s Tri-Activ Disinfectant Spray For Multi-Surfaces is 99.9% Effective Against the Covid-19 Virus in 1 Minute


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Piramal Pharma Consumer Products Division’s Tri-Activ Disinfectant Spray For Multi-Surfaces is 99.9% Effective Against the Covid-19 Virus in 1 Minute
This spray has been tested and proven for efficacy as well as fast action on the Covid19 virus by an independent accredited US-based lab.

Piramal Pharma Limited’s Consumer Products Division today announced that its Tri-Activ Disinfectant Spray for multi-surfaces is “99.9% effective against the Covid-19 virus in 1 minute”. This spray has been tested and proven for efficacy as well as fast action on the Covid19 virus by an independent accredited US-based lab. The Tri-Activ Disinfectant Spray can be used to disinfect a variety of hard and soft surfaces including delivery parcels, non-leather car interiors and shoes, glass table tops, door handles and knobs, lift buttons, children’s toys and cycles, and non-satin clothes, sofas, curtains and mattresses. Its regular usage also keeps fungus and mould away from high touch surfaces. This spray is available in 3 pack sizes – 100ml (convenient to carry), 230ml (medium) and 500ml (large) at affordable prices. Nandini Piramal, Director, Piramal Pharma Limited said, “With the threat of Covid-19 and the uncertainty around it, the demand for sanitization and disinfectant products is on a significant rise as personal hygiene and environment sanitization is of paramount importance. Piramal’s Consumer Products Division launched the Tri-Active range of products with an aim to provide complete protection to its consumers by catering to their various personal and household needs. Our Tri-Activ Disinfectant Spray is tested and proven to be 99.9% effective against the corona virus in 1 minute. Committed to our purpose of Doing Well and Doing Good, we’re now enabling more consumers to make their world ‘Tri-Activ’ safe.” Piramal’s Consumer Products Division recently launched its disinfectant product portfolio under the brand name Tri-Activ in Q1 FY2021. The products under this portfolio offer customers a complete range of protection from virus, bacteria and other germs. In addition to having adopted a WHO approved hand sanitizer liquid, this range comprises a variety of products including disinfectant spray, hand sanitizer gel, multi-purpose disinfectant liquid, as well as a 6-layer protective face mask with an anti-virus coating. Adopting an e-commerce first strategy, the complete Tri-Activ range of products is available across all major sales channels including general trade, modern trade and leading e-commerce platforms. Tri-Activ sprays and sanitizers are available at 50,000+ outlets in 177 townsin India across chemist and non-chemist channels. Currently, ~3,000 Tri-Activ range products are sold daily over e-commerce, contributing to ~50% of the range’s total sales.

Tags : #LatestPharmaNewsOct27 #LatestPiramalNewsOct27 #DisinfectantsprayforCOVID19 #TriActivDisinfectantSpray

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026